OCX RSI Chart
Last 7 days
2.1%
Last 30 days
13.9%
Last 90 days
-1.7%
Trailing 12 Months
-42.0%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.4M | 0 | 0 | 0 |
2023 | 6.5M | 6.8M | 7.1M | 7.2M |
2022 | 8.0M | 6.2M | 5.3M | 2.0M |
2021 | 2.3M | 4.2M | 4.6M | 7.7M |
2020 | 0 | 0 | 0 | 1.2M |
2019 | 0 | 0 | 0 | 0 |
2018 | 0 | 0 | 0 | 0 |
2017 | 0 | 0 | 0 | 293.0K |
2016 | 0 | 0 | 0 | 0 |
2015 | 0 | 0 | 0 | 397.0K |
2014 | 0 | 0 | 0 | 569.0K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 11, 2024 | broadwood partners, l.p. | bought | 7,057,690 | 2.9164 | 2,420,000 | - |
Apr 11, 2024 | arno andrew | bought | 99,999 | 2.95 | 33,898 | - |
Apr 11, 2024 | riggs josh | bought | 10,000 | 2.95 | 3,390 | ceo and president |
Apr 11, 2024 | broadwood partners, l.p. | bought | - | - | - | - |
Jun 30, 2023 | gutfreund john peter | sold | - | - | -3,085,050 | - |
Jun 23, 2023 | silverman lou | acquired | - | - | 25,000 | - |
Jun 23, 2023 | kingsley alfred d | acquired | - | - | 20,000 | - |
Jun 23, 2023 | last andrew j. | acquired | - | - | 20,000 | - |
Jun 23, 2023 | arno andrew | acquired | - | - | 30,000 | - |
Jun 14, 2023 | kingsley alfred d | bought | 6,447 | 0.2149 | 30,000 | - |
Which funds bought or sold OCX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | COMERICA BANK | reduced | -4.17 | 7.00 | 67.00 | -% |
May 16, 2024 | AWM Investment Company, Inc. | unchanged | - | 339,429 | 2,210,060 | 0.29% |
May 15, 2024 | STATE STREET CORP | unchanged | - | 7,330 | 47,727 | -% |
May 15, 2024 | MORGAN STANLEY | added | 0.19 | 53,575 | 361,008 | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | reduced | -2.78 | 74.00 | 615 | -% |
May 15, 2024 | PURA VIDA INVESTMENTS, LLC | reduced | -10.73 | 67,784 | 1,535,110 | 0.26% |
May 15, 2024 | Tower Research Capital LLC (TRC) | reduced | -43.54 | -2,816 | 5,508 | -% |
May 15, 2024 | BROADWOOD CAPITAL INC | unchanged | - | 1,078,900 | 7,351,560 | 0.55% |
May 15, 2024 | Royal Bank of Canada | reduced | -91.12 | -2,000 | - | -% |
May 14, 2024 | Qube Research & Technologies Ltd | unchanged | - | 1.00 | 3.00 | -% |
Unveiling Oncocyte Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Oncocyte Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
DHR | 196.9B | 23.7B | 44.73 | 8.29 | ||||
A | 45.2B | 6.7B | 36.57 | 6.71 | ||||
IDXX | 44.9B | 3.7B | 51.83 | 12.06 | ||||
DGX | 16.0B | 9.3B | 18.95 | 1.73 | ||||
NTRA | 13.1B | 1.2B | -35.76 | 10.81 | ||||
MEDP | 12.2B | 2.0B | 38.94 | 6.2 | ||||
CRL | 11.4B | 4.1B | 26.02 | 2.78 | ||||
EXAS | 9.3B | 2.5B | -38.69 | 3.67 | ||||
MID-CAP | ||||||||
GH | 3.1B | 603.7M | -6.73 | 5.14 | ||||
NEOG | 2.9B | 929.2M | 1.9K | 3.16 | ||||
SMALL-CAP | ||||||||
CDNA | 808.3M | 275.1M | -4.41 | 2.94 | ||||
ACRS | 84.8M | 31.1M | -1.1 | 2.73 | ||||
AWH | 33.0M | 9.2M | -2.24 | 3.6 | ||||
APDN | 2.5M | 5.5M | -0.2 | 0.45 | ||||
BIOC | 183.8K | 25.9M | -0.01 | 0.01 |
Oncocyte Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -43.9% | 176,000 | 314,000 | 429,000 | 463,000 | 5,959,000 | 274,000 | 67,000 | 237,000 | 1,424,000 | 3,589,000 | 984,000 | 2,030,000 | 1,124,000 | 503,000 | 555,000 | 143,000 | - | - | - | - | - |
Cost Of Revenue | -38.4% | 252,000 | 409,000 | 159,000 | 169,000 | 265,000 | 278,000 | 314,000 | 183,000 | 105,000 | 2,220,000 | 860,000 | 1,350,000 | 738,000 | 716,000 | 601,000 | 365,000 | 173,000 | - | - | - | - |
Gross Profit | 16.2% | -98,000 | -117,000 | 248,000 | 272,000 | 10,000 | -27,000 | -269,000 | 31,000 | 247,000 | 2,601,000 | -866,000 | -394,000 | 79,000 | - | -46,000 | -222,000 | - | - | - | - | - |
Operating Expenses | -42.9% | 9,169,000 | 16,062,000 | 6,761,000 | 8,566,000 | -5,840,000 | 11,621,000 | 1,437,000 | 1,657,000 | 3,264,000 | 17,794,000 | 12,738,000 | 13,174,000 | 11,439,000 | 5,967,500 | 6,198,000 | 8,546,000 | 8,447,000 | 7,523,000 | 5,257,000 | 5,462,000 | 3,997,000 |
S&GA Expenses | 45.4% | 846,000 | 582,000 | 713,000 | 805,000 | 695,000 | 334,000 | 405,000 | 127,000 | 266,000 | 3,309,000 | 2,931,000 | 2,673,000 | 2,254,000 | 1,874,000 | 1,568,000 | 1,562,000 | 1,490,000 | 1,011,000 | 630,000 | 318,000 | 205,000 |
R&D Expenses | -14.8% | 2,169,000 | 2,547,000 | 2,185,000 | 2,435,000 | 2,127,000 | 1,378,000 | 1,472,000 | 2,444,000 | 2,007,000 | 4,591,000 | 3,142,000 | 2,537,000 | 3,361,000 | 1,800,000 | 2,615,000 | 3,225,000 | 2,159,000 | 2,318,000 | 1,625,000 | 1,508,000 | 1,343,000 |
EBITDA Margin | -756.9% | -27.87 | -3.25 | -2.68 | -2.15 | -1.17 | -8.59 | -7.74 | -8.55 | -8.03 | -9.41 | -9.43 | -8.77 | -14.59 | - | - | - | - | - | - | - | - |
Interest Expenses | 100.0% | - | -160,000 | 117,000 | 1,000 | -10,000 | -18,000 | -14,000 | -21,000 | -30,000 | -42,000 | -50,000 | -49,000 | -68,000 | -77,000 | -78,000 | -75,000 | -22,000 | 16,500 | 135,000 | 167,000 | -19,000 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | -97,000 | - | -1,794,000 | -7,564,000 | 159,000 | - | -2,190,000 | 1,095,000 | - | - | - | - |
Earnings Before Taxes | 42.9% | -9,129,000 | -15,992,000 | -6,489,000 | -8,333,000 | 5,959,000 | -12,017,000 | -1,818,000 | -1,364,000 | -3,413,000 | -35,788,000 | -13,800,000 | -12,287,000 | -11,483,000 | -6,468,000 | -6,783,000 | -9,108,000 | -8,827,000 | -7,954,000 | -5,225,000 | -5,383,000 | -3,864,000 |
EBT Margin | -733.2% | -28.90 | -3.47 | -2.93 | -2.40 | -1.41 | -9.30 | -7.97 | -8.72 | -8.13 | -9.49 | -9.49 | -8.79 | -14.56 | - | - | - | - | - | - | - | - |
Net Income | 42.9% | -9,129,000 | -15,992,000 | -6,489,000 | -8,333,000 | 3,033,000 | -44,978,000 | -9,333,000 | -8,300,000 | -10,291,000 | -35,885,000 | -13,800,000 | -10,493,000 | -3,919,000 | -6,309,000 | -6,783,000 | -9,108,000 | -7,732,000 | -7,954,000 | -5,225,000 | -5,383,000 | -3,864,000 |
Net Income Margin | -645.4% | -28.90 | -3.88 | -7.97 | -8.81 | -9.11 | -36.41 | -12.00 | -10.95 | -8.78 | -8.30 | -6.11 | -4.95 | -7.37 | - | - | - | - | - | - | - | - |
Free Cashflow | 20.1% | -3,854,000 | -4,826,000 | -2,259,000 | -6,832,000 | -9,672,000 | -10,450,000 | -12,255,000 | -12,365,000 | -14,838,000 | -7,466,000 | -11,377,000 | -8,668,000 | -10,677,000 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -5.2% | 71.00 | 75.00 | 82.00 | 88.00 | 83.00 | 100 | 157 | 171 | 146 | 160 | 168 | 177 | 129 | 55.00 | 58.00 | 63.00 | 60.00 | 40.00 | 33.00 | 38.00 | 42.00 |
Current Assets | -38.9% | 7.00 | 11.00 | 17.00 | 21.00 | 16.00 | 26.00 | 37.00 | 49.00 | 25.00 | 39.00 | 48.00 | 50.00 | 63.00 | 9.00 | 12.00 | 18.00 | 18.00 | 23.00 | 20.00 | 37.00 | 41.00 |
Cash Equivalents | -40.6% | 6.00 | 9.00 | 14.00 | 17.00 | 12.00 | 20.00 | 32.00 | 45.00 | 20.00 | 33.00 | 43.00 | 47.00 | 59.00 | 7.00 | 10.00 | 17.00 | 17.00 | 22.00 | 19.00 | 36.00 | 39.00 |
Net PPE | 14.7% | 5.00 | 5.00 | - | - | 5.00 | 9.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.00 | 0.00 |
Goodwill | - | - | - | - | - | - | - | 19.00 | 19.00 | 19.00 | 19.00 | 18.00 | 24.00 | 9.00 | 9.00 | 9.00 | 9.00 | 9.00 | - | - | - | - |
Liabilities | 9.6% | 54.00 | 49.00 | 39.00 | 39.00 | 39.00 | 60.00 | 75.00 | 83.00 | 89.00 | 94.00 | 69.00 | 75.00 | 5.00 | 22.00 | 23.00 | 24.00 | 23.00 | 9.00 | 3.00 | 4.00 | 3.00 |
Current Liabilities | 15.7% | 8.00 | 7.00 | 8.00 | 8.00 | 9.00 | 12.00 | 13.00 | 14.00 | 14.00 | 14.00 | 13.00 | 20.00 | 10.00 | 9.00 | 9.00 | 7.00 | 7.00 | 4.00 | 3.00 | 4.00 | 3.00 |
Shareholder's Equity | -43.4% | 12.00 | 20.00 | 38.00 | 44.00 | 38.00 | 34.00 | 77.00 | 83.00 | 57.00 | 65.00 | 99.00 | 103 | 107 | 33.00 | 35.00 | 40.00 | 37.00 | 31.00 | 29.00 | 34.00 | 38.00 |
Retained Earnings | -3.1% | -299 | -289 | -272 | -265 | -257 | -260 | -215 | -206 | -198 | -187 | -151 | -138 | -127 | -123 | -117 | -110 | -101 | -93.74 | -85.79 | -80.57 | -75.18 |
Shares Outstanding | 0.1% | 8.00 | 8.00 | 8.00 | 8.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 4.00 | 4.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 19.00 | - | - | - | 69.00 | - | - | - | 298 | - | - | - | 70.00 | - | - | - | 47.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 16.0% | -3,830 | -4,562 | -2,259 | -6,832 | -9,672 | -9,648 | -11,396 | -11,247 | -13,277 | -7,065 | -10,983 | -8,058 | -9,835 | -6,144 | -6,005 | -6,961 | -6,870 | -5,306 | -4,851 | -2,840 | -6,718 |
Share Based Compensation | -13.6% | 418 | 484 | 608 | 834 | 834 | 2,619 | 3,181 | 2,232 | 2,010 | 1,705 | 1,850 | 1,996 | 1,290 | 985 | 1,784 | 1,361 | 937 | 787 | 821 | 701 | 686 |
Cashflow From Investing | -110.0% | -24.00 | 241 | -1,296 | 1,495 | -1,372 | -802 | -859 | -1,118 | -1,561 | -401 | -394 | -4,894 | -8,272 | -498 | -526 | -4,533 | -6,191 | -1,216 | -11,235 | -11.00 | 47.00 |
Cashflow From Financing | 100.0% | - | -30.00 | -30.00 | 12,274 | -28.00 | -100 | -528 | 36,789 | -355 | -269 | 8,215 | 547 | 69,871 | 3,493 | 28.00 | 11,713 | 7,565 | 10,850 | -296 | -580 | 37,894 |
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands | 3 Months Ended | |||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |||
Income Statement [Abstract] | ||||
Net revenue | $ 176,000 | $ 297,000 | ||
Cost of revenues | 252,000 | 265,000 | ||
Cost of revenues – amortization of acquired intangibles | 22,000 | 22,000 | ||
Gross (loss) profit | (98,000) | 10,000 | ||
Operating expenses: | ||||
Research and development | 2,169,000 | 2,127,000 | ||
Sales and marketing | 846,000 | 695,000 | ||
General and administrative | 2,673,000 | 3,412,000 | ||
Change in fair value of contingent consideration | 3,312,000 | (18,307,000) | ||
Impairment loss | 4,950,000 | |||
Impairment loss on held for sale assets | 169,000 | 1,283,000 | ||
Total operating expenses (credits) | 9,169,000 | (5,840,000) | ||
(Loss) income from operations | (9,267,000) | 5,850,000 | ||
Other (expenses) income: | ||||
Interest expense | (15,000) | (11,000) | ||
Unrealized gain on marketable equity securities | 121,000 | |||
Other income (expenses), net | 153,000 | (1,000) | ||
Total other income | 138,000 | 109,000 | ||
(Loss) income before income taxes | (9,129,000) | 5,959,000 | ||
Income taxes | ||||
(Loss) income from continuing operations | (9,129,000) | 5,959,000 | ||
Loss from discontinued operations (Note 11) | (2,926,000) | |||
Net (loss) income | (9,129,000) | 3,033,000 | ||
Net (loss) income per share: | ||||
Net (loss) income from continuing operations - basic | [1] | (9,335) | 4,899 | |
Net (loss) income from continuing operations - diluted | [1] | (9,335) | 4,899 | |
Net loss from discontinued operations - basic | [1] | (2,502) | ||
Net loss from discontinued operations - diluted | [1] | (2,502) | ||
Net (loss) income attributable to common stockholders - basic | [1] | (9,335) | 2,397 | |
Net (loss) income attributable to common stockholders - diluted | [1] | $ (9,335) | $ 2,397 | |
Net (loss) income from continuing operations per share - basic | $ (1.13) | $ 0.82 | ||
Net (loss) income from continuing operations per share - diluted | (1.13) | 0.82 | ||
Net loss from discontinued operations per share - basic | (0.42) | |||
Net loss from discontinued operations per share - diluted | (0.42) | |||
Net (loss) income attributable to common stockholders per share - basic | (1.13) | 0.40 | ||
Net (loss) income attributable to common stockholders per share - diluted | $ (1.13) | $ 0.40 | ||
Weighted average shares outstanding - basic | 8,264 | 5,958 | ||
Weighted average shares outstanding - diluted | 8,264 | 5,963 | ||
|
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
CURRENT ASSETS | ||
Cash and cash equivalents | $ 5,578 | $ 9,432 |
Accounts receivable, net of allowance for credit losses of $2 and $5, respectively | 161 | 484 |
Prepaid expenses and other current assets | 735 | 643 |
Assets held for sale | 61 | 139 |
Total current assets | 6,535 | 10,698 |
NONCURRENT ASSETS | ||
Right-of-use and financing lease assets, net | 2,199 | 1,637 |
Machinery and equipment, net, and construction in progress | 3,528 | 3,799 |
Intangible assets, net | 56,573 | 56,595 |
Restricted cash | 1,700 | 1,700 |
Other noncurrent assets | 438 | 463 |
TOTAL ASSETS | 70,973 | 74,892 |
CURRENT LIABILITIES | ||
Accounts payable | 908 | 953 |
Accrued compensation | 2,427 | 1,649 |
Accrued royalties | 1,116 | 1,116 |
Accrued expenses and other current liabilities | 741 | 452 |
Accrued severance from acquisition | 2,314 | 2,314 |
Right-of-use liabilities, current | 821 | 665 |
Current liabilities of discontinued operations (Note 11) | 45 | |
Total current liabilities | 8,327 | 7,194 |
NONCURRENT LIABILITIES | ||
Right-of-use liabilities, noncurrent | 2,514 | 2,204 |
Contingent consideration liabilities | 43,212 | 39,900 |
TOTAL LIABILITIES | 54,053 | 49,298 |
Commitments and contingencies (Note 6) | ||
Series A Redeemable Convertible Preferred Stock, no par value; stated value $1,000 per share; 5 shares issued and outstanding at March 31, 2024 and December 31, 2023; aggregate liquidation preference of $5,376 and $5,296 as of March 31, 2024 and December 31, 2023, respectively | 5,332 | 5,126 |
SHAREHOLDERS’ EQUITY | ||
Preferred stock, no par value, 5,000 shares authorized; no shares issued and outstanding | ||
Common stock, no par value, 230,000 shares authorized; 8,273 and 8,261 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively | 310,553 | 310,295 |
Accumulated other comprehensive income | 40 | 49 |
Accumulated deficit | (299,005) | (289,876) |
Total shareholders’ equity | 11,588 | 20,468 |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ 70,973 | $ 74,892 |